~56 spots leftby Apr 2026

Computerized Decision Support for Pulmonary Hypertension

(CTEPH-DETECT Trial)

Recruiting in Palo Alto (17 mi)
GP
Overseen byGregory Piazza, MD, MS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Brigham and Women's Hospital
No Placebo Group

Trial Summary

What is the purpose of this trial?

To address the knowledge gap that exists among providers resulting in underdiagnosis of chronic thromboembolic pulmonary hypertension (CTEPH), the investigators have devised this 400-patient single-center Quality Improvement Initiative in the form of a randomized controlled trial of an EPIC Best Practice Advisory (BPA) on-screen alert versus no notification to increase echocardiographic screening for CTEPH and the diagnosis of CTEPH in patients with prior pulmonary embolism (PE) and symptoms/signs suggestive of pulmonary hypertension or recent pulmonary testing suggesting unexplained respiratory symptoms at 3 months. Aim #1: To determine the impact of a Best Practice Advisory (BPA), using the EPIC Electronic Health Record computerized decision support (CDS) software, on echocardiographic screening for CTEPH in patient with prior PE and symptoms/signs suggestive of pulmonary hypertension or recent pulmonary testing suggesting unexplained respiratory symptoms. Aim #2: To determine the impact of an EPIC BPA on the diagnosis of CTEPH in patient with prior PE and symptoms/signs suggestive of pulmonary hypertension or recent pulmonary testing suggesting unexplained respiratory symptoms.

Research Team

GP

Gregory Piazza, MD, MS

Principal Investigator

BWH

Eligibility Criteria

This trial is for adults who've had a pulmonary embolism, are experiencing symptoms like fatigue or chest pain, or have unexplained respiratory issues on tests. They haven't had an echocardiogram in the last 6 months and are seen at specific clinics.

Inclusion Criteria

You have not had a heart ultrasound in the last 6 months.
I have symptoms or test results suggesting high blood pressure in the lungs.
I am 18 years old or older.
See 2 more

Treatment Details

Interventions

  • On-screen computerized decision support alert (Behavioral)
Trial OverviewThe study is testing if a computer alert for doctors increases screening and diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) in patients with past pulmonary embolisms showing certain symptoms.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: AlertExperimental Treatment1 Intervention
On-screen computerized decision support alert during the outpatient clinical encounter that notifies the provider that the patient should be screened for CTEPH
Group II: No AlertActive Control1 Intervention
No provider notification

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brigham and Women's Hospital

Lead Sponsor

Trials
1,694
Recruited
14,790,000+
Dr. William Curry profile image

Dr. William Curry

Brigham and Women's Hospital

Chief Medical Officer

MD from Columbia University College of Physicians and Surgeons

Dr. Scott Schissel profile image

Dr. Scott Schissel

Brigham and Women's Hospital

Chief Executive Officer since 2021

MD from Columbia University College of Physicians and Surgeons

Bayer

Industry Sponsor

Trials
2,291
Recruited
25,560,000+
Founded
1863
Headquarters
Leverkusen, Germany
Known For
Pharmaceutical Innovations
Top Products
Aspirin, Aleve, Yaz, Nexavar

Bill Anderson

Bayer

Chief Executive Officer since 2023

BSc in Chemical Engineering from the University of Texas, MSc in Chemical Engineering and Management from MIT

Michael Devoy profile image

Michael Devoy

Bayer

Chief Medical Officer since 2014

MD, PhD